Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy

Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), today announced that Dr. Michael Schaeffer has been appointed to the position of Executive Vice President of Business and Strategy, effective August 2018. Dr. Schaeffer brings more than 15 years of experience across pharma and biotech in strategic business development, scientific project and alliance management to Probiodrug.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...